Kore Private Wealth’s Abiomed Inc ABMD Stock Holding History

Kore Private Wealth’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-3	Closed	–	–	1300
2020 Q1	$0	Sell	3 -162	-98%	-$26.9K	﹤0.01%	1228
2019 Q4	$28K	Buy	+165	New	+$30.6K	0.01%	576

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Kore Private Wealth's ABMD Position: Q2 2020 in Review

Kore Private Wealth sold out of Abiomed Inc (ABMD) in Q2 2020, closing a stake of 3 shares.

Kore Private Wealth first reported a position in ABMD in Q4 2019 and held it in 2 quarters. The position peaked at $28K in Q4 2019. 460 funds tracked by Wall St. Rank hold ABMD as of Q2 2020.

Kore Private Wealth reported no remaining Abiomed Inc position as of Q2 2020 after selling out during the quarter.
Kore Private Wealth sold 3 Abiomed Inc shares in Q2 2020.
Kore Private Wealth first reported a position in Abiomed Inc in Q4 2019 and held it in 2 quarters.
Kore Private Wealth's Abiomed Inc position peaked at $28K in Q4 2019.
460 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2020.

Based on Kore Private Wealth's 13F filing for Q2 2020, filed 14 Aug 2020.